Parallel Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-52,441
Closed -$2.68M – 3713
2024
Q4
$2.68M Buy
52,441
+23
+0% +$1.13K 0.06% 219
2024
Q3
$2.16M Buy
52,418
+2
+0% +$96 0.05% 232
2024
Q2
$2.52M Sell
52,416
-80
-0.2% -$3.55K 0.06% 212
2024
Q1
$2.52M Sell
52,496
-27
-0.1% -$1.44K 0.07% 204
2023
Q4
$3.41M Buy
52,523
+827
+2% +$49.8K 0.1% 152
2023
Q3
$3.38M Buy
51,696
+1,313
+3% +$82.6K 0.11% 146
2023
Q2
$2.93M Sell
50,383
-23
-0% -$1.45K 0.09% 164
2023
Q1
$3.11M Sell
50,406
-93
-0.2% -$5.58K 0.1% 156
2022
Q4
$3.21M Sell
50,499
-19
-0% -$1.38K 0.14% 113
2022
Q3
$3.67M Buy
50,518
+10
+0% +$745 0.17% 91
2022
Q2
$3.43M Buy
50,508
+128
+0.3% +$9.2K 0.16% 95
2022
Q1
$4.57M Buy
50,380
+28
+0.1% +$2.29K 0.18% 85
2021
Q4
$4.6M Hold
50,352
– – 0.17% 96
2021
Q3
$4.08M Hold
50,352
– – 0.16% 101
2021
Q2
$4.7M Hold
50,352
– – 0.2% 81
2021
Q1
$5.39M Sell
50,352
-9,500
-16% -$986K 0.25% 70
2020
Q4
$5.22M Buy
+59,852
New +$4.23M 0.28% 63

Other funds holding NARI

Parallel Advisors's NARI Position: Q1 2025 in Review

Parallel Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 52,441 shares — an estimated $2.68M sold.

Parallel Advisors first reported a position in NARI in Q4 2020 and held it in 17 quarters. The position peaked at $5.39M in Q1 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Parallel Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Parallel Advisors sold 52,441 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.68M.
  • Parallel Advisors first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 17 quarters.
  • Parallel Advisors's Inari Medical, Inc. Common Stock position peaked at $5.39M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.